ROIV
Roivant Sciences Ltd
$41.02
+0.49% (+$0.20)
Volume
7.56M
52W High
$42.50
52W Low
$13.81
Market Cap
$25.00B
Next Earnings Report
Last Reported
Aug 6, 2026 Met
Actual: -$0.45
vs. Consensus: -$0.45
Price Chart
EPS History: Consensus vs Actual
Last 9 quartersPrice Movement Around Earnings
Q2 2026
Aug 6, 2026
1-Day:
+3.47%
5-Day:
+0.37%
Q1 2026
Aug 6, 2026
1-Day:
+3.47%
5-Day:
+0.37%
Q2 2026
Jul 1, 2026
1-Day:
+0.29%
5-Day:
+1.03%
Q4 2025
May 20, 2026
1-Day:
-4.72%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $2.0M | -77.8% | 65.0% | -10,000.0% | -$265.9M |
| Q3'25 | $1.6M | -64.9% | 92.9% | -10,000.0% | -$113.5M |
| Q2'25 | $2.2M | -72.8% | 92.9% | -10,000.0% | -$223.4M |
| Q1'25 | $7.6M | -16.1% | 97.3% | -3,764.4% | -$206.5M |
| Q4'24 | $9.0M | -42.1% | 97.1% | -3,042.6% | $169.4M |
| Q3'24 | $4.5M | +22.7% | 94.8% | -7,636.0% | -$230.2M |
| Q2'24 | $8.0M | -63.1% | 97.3% | -1,279.5% | $95.3M |
| Q1'24 | $9.0M | -67.1% | 75.1% | -2,293.1% | -$151.1M |
Company Information
Symbol
ROIV
Company
Roivant Sciences Ltd
Market Cap
$25.00B